
zzso zzso is a zzso that has shown zzso activity in a range of zzso zzso models, although its mechanism of action is zzso zzso studies have indicated the absence of zzso side effects such as zzso and gastrointestinal zzso The present phase I trial was carried out in nine patients at doses ranging up to 133 zzso The major zzso up to that dose were mild, zzso zzso zzso and zzso No zzso or zzso toxicity was zzso zzso zzso were assessed at a dose level that was effective in experimental zzso and compared with human zzso parameters derived from this zzso The results indicated the clinical possibility of reaching peak drug levels associated with experimental zzso However, no responses were seen at the doses zzso This study was terminated prior to its completion due to an unexplained loss of activity against zzso zzso since September zzso No significant loss of the in zzso zzso activity originally reported by zzso et zzso zzso was zzso zzso reasons for the apparent loss of in zzso activity have been zzso investigated, but no cause has been zzso zzso clinical trials with zzso zzso have been zzso 

